Study of Comprehensive ANd Multimodal Marker-based Cohort of Progressive Supranuclear Palsy(PSP)
NCT05579301 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 130
Last updated 2022-10-13
Summary
The purpose of this cohort study is to develop a reliable biomarker in progressive nuclear palsy (PSP).
Conditions
Sponsors & Collaborators
-
SMG-SNU Boramae Medical Center
collaborator OTHER -
Seoul National University Hospital
lead OTHER
Principal Investigators
-
Jee-Young Lee, M.D. · SMG-SNU Boramae Medical Center
Eligibility
- Min Age
- 50 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-12-19
- Primary Completion
- 2024-12-19
- Completion
- 2025-02-28
Countries
- South Korea
Study Locations
More Related Trials
-
PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UK
NCT02778607 ·Status: UNKNOWN
-
Biomarkers in Parkinsonian Syndromes
NCT06501469 ·Status: RECRUITING
-
Research of Biomarkers in Parkinson Disease
NCT00465790 ·Status: COMPLETED
-
A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes
NCT05956834 ·Status: ACTIVE_NOT_RECRUITING
-
Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies
NCT07240805 ·Status: NOT_YET_RECRUITING
-
Personalized Parkinson Project PSP Cohort
NCT05501431 ·Status: COMPLETED
-
Parkinson's Repository of Biosamples and Network Datasets (Tracking Parkinson's)
NCT02881099 ·Status: COMPLETED
-
Serum Biomarkers in Parkinson's Disease at Different Stages
NCT05769699 ·Status: RECRUITING ·Phase: NA
-
Diagnostic and Prognostic Biomarkers in Parkinson Disease
NCT00653783 ·Status: UNKNOWN
-
Early Biomarkers of Neurodegeneration in Parkinsonian Syndromes
NCT06155942 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Postural Instability in Progressive Supranuclear Palsy
NCT01563276 ·Status: COMPLETED
-
Biomarkers in Neural Disorders
NCT02761707 ·Status: COMPLETED
-
One-year Follow-up of Iron in Basal Ganglia - R2*: a Biomarker of Parkinson's Disease Progression?
NCT02816645 ·Status: UNKNOWN ·Phase: NA
-
Prognostic Value of FP-CIT-SPECT in Parkinson´s Disease
NCT01038310 ·Status: COMPLETED
-
Non-motor Symptoms and Brain Dopamine Transporter Binding
NCT02650843 ·Status: ACTIVE_NOT_RECRUITING
-
Utilisation of Health Services and Quality of Life in Patients With Atypical Parkinsonian Syndromes
NCT06645626 ·Status: RECRUITING
-
Identification of a Biomarker Predictive of Evolution of Parkinson Disease
NCT03230526 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Screening and Natural History: Primary Lateral Sclerosis and Related Disorders
NCT00015444 ·Status: COMPLETED
-
Quantification Tools for a Novel Tau PET Marker in a Rare Neurological Disease: 18F-PI-2620 in Progressive Supranuclear Palsy
NCT07105384 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Parkinson Atypical Rating of Oculometric Patterns Evaluated Routinely
NCT06597071 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
NCT05699460 ·Status: ACTIVE_NOT_RECRUITING
-
Unstructured Eye Tracking as a Diagnostic and Prognostic Biomarker in Parkinsonian Disorders
NCT05638477 ·Status: UNKNOWN ·Phase: NA
-
Temporal Relationship Between Motor Fluctuations and Nonmotor Fluctuations
NCT02060695 ·Status: RECRUITING
-
Electromyography Signals as Biomarkers for Parkinson's Disease
NCT02168504 ·Status: COMPLETED
-
Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 Parkinsonism
NCT01759888 ·Status: COMPLETED ·Phase: PHASE2